» Articles » PMID: 16765679

Family History of Inflammatory Bowel Disease in Patients with Idiopathic Ocular Inflammation

Overview
Journal Am J Ophthalmol
Specialty Ophthalmology
Date 2006 Jun 13
PMID 16765679
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the prevalence of a family history (FMH) of inflammatory bowel disease (IBD) in patients with idiopathic ocular inflammation (OI).

Design: Retrospective observational study.

Methods: Medical records of idiopathic OI patients seen between January 1995 and June 2005 in the University of Illinois Uveitis Clinic were screened for a FMH of IBD. FMH included first, second, and third degree relatives.

Results: 727 (32.8%) patients had idiopathic OI. 26 of 727 (3.6%) and 10 of 727 (1.4%) reported a FMH of ulcerative colitis (UC) and Crohn's disease, respectively. 16 (2.2%) patients with a FMH of indeterminate colitis were excluded from subsequent comparisons. The prevalence of a FMH of IBD among patients with idiopathic OI was 3- to 15-fold higher than the prevalence of UC and Crohn's in the general population (0.055% to 0.27%). Keratoiritis was more common and granulomatous disease less frequent in patients with a FMH of IBD (P = .014 and .019). Patients tested 26.3% with a FMH of IBD, and 66.7% of patients tested with IBD themselves, were HLA-B27 positive (odds ratio [OR] 5.6, 95% confidence interval [CI] 0.77 to 45.8), compared with 40.1% of patients with neither (OR 1.87, 95% CI 0.61 to 6.83).

Conclusions: A FMH of IBD may be an independent risk factor for the development of OI. In contrast to the subgroup of patients with a personal history of IBD, HLA-B27 may not be an appropriate marker in the subgroup of patients with merely a FMH of IBD, emphasizing the importance of investigating other immunologic factors that may predispose patients with IBD and their relatives to OI.

Citing Articles

Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centre.

Lewandowski K, Kaniewska M, Karlowicz K, Wiecek M, Tulewicz-Marti E, Celmer P Prz Gastroenterol. 2025; 16(4):397-407.

PMID: 39810871 PMC: 11726220. DOI: 10.5114/pg.2024.144988.


Inflammatory eye disease is a risk factor for future microscopic colitis: A nationwide population-based matched case control study.

Bergman D, Ebrahimi F, Sun J, Norin C, Mollazadegan K, Ludvigsson J United European Gastroenterol J. 2024; 12(8):1081-1090.

PMID: 38963730 PMC: 11485298. DOI: 10.1002/ueg2.12623.


Ophthalmological Manifestations in Inflammatory Bowel Diseases: Keep an Eye on It.

Migliorisi G, Vella G, Dal Buono A, Gabbiadini R, Busacca A, Loy L Cells. 2024; 13(2).

PMID: 38247834 PMC: 10814681. DOI: 10.3390/cells13020142.


New pattern of individualized management of chronic diseases: focusing on inflammatory bowel diseases and looking to the future.

Guo X, Cai L, Cao Y, Liu Z, Zhang J, Liu D Front Med (Lausanne). 2023; 10:1186143.

PMID: 37265491 PMC: 10231387. DOI: 10.3389/fmed.2023.1186143.


The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Li J, Chiang C, Chen S, Lin J, Tsai Y Int J Environ Res Public Health. 2022; 19(23).

PMID: 36497759 PMC: 9737331. DOI: 10.3390/ijerph192315683.